🇺🇸 FDA
Patent

US 10507239

V1/V2 fragments of a HIV-1 envelope glycoprotein

granted A61KA61K39/12A61K39/21

Quick answer

US patent 10507239 (V1/V2 fragments of a HIV-1 envelope glycoprotein) held by The Regents of the University of California expires Mon Dec 12 2039 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
The Regents of the University of California
Grant date
Tue Dec 17 2019 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Dec 12 2039 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
12
CPC classes
A61K, A61K39/12, A61K39/21, A61P, A61P31/18